Cytogenetic and molecular aberrations and worse outcome for male patients in systemic mastocytosis

Kluin-Nelemans H. C., Jawhar M., Reiter A., van Anrooij B., Gotlib J., Hartmann K., ...Daha Fazla

THERANOSTICS, cilt.11, sa.1, ss.292-303, 2021 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 11 Sayı: 1
  • Basım Tarihi: 2021
  • Doi Numarası: 10.7150/thno.51872
  • Dergi Adı: THERANOSTICS
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, BIOSIS, EMBASE, MEDLINE, Directory of Open Access Journals
  • Sayfa Sayıları: ss.292-303
  • İstanbul Üniversitesi Adresli: Hayır

Özet

In systemic mastocytosis (SM), the clinical features and survival vary greatly. Patient-related factors determining the outcome in SM are largely unknown.